Mulpleta Tablet, Film Coated
NDC Package 84230-551-07

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mulpleta (lusutrombopag) tablets is a medication used by people with chronic liver disease and a certain blood disorder (low platelet count) who are scheduled to have a medical or dental procedure. This formulation utilizes a tablet, film coated delivery system. Marketed by Vancocin Italia Srl, this product is identified by NDC 84230-551 and is authorized under FDA application NDA210923.

Identification & Billing

NDC Package Code
84230-551-07
Package Description
1 DOSE PACK in 1 CARTON / 7 TABLET, FILM COATED in 1 DOSE PACK
Product Code
84230-551
11-Digit Billing Format
84230055107
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Mulpleta
Non-Proprietary Name
Lusutrombopag
Substance Name
Lusutrombopag
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
LUSUTROMBOPAG 3 mg/1
Usage Information
This medication is used by people with chronic liver disease and a certain blood disorder (low platelet count) who are scheduled to have a medical or dental procedure. Having a low platelet count increases the risk of too much bleeding during certain procedures. This medication increases the production of platelets by your body to help prevent too much bleeding from the procedure.

Regulatory & Marketing

Labeler Name
Vancocin Italia Srl
Product Type
Human Prescription Drug
FDA Application #
NDA210923
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-09-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84230-551-07 identifies a specific commercial package of 1 dose pack in 1 carton / 7 tablet, film coated in 1 dose pack of Mulpleta, a human prescription drug labeled by Vancocin Italia Srl. This tablet, film coated is formulated for oral use and contains lusutrombopag as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Vancocin Italia Srl on December 09, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used by people with chronic liver disease and a certain blood disorder (low platelet count) who are scheduled to have a medical or dental procedure. Having a low platelet count increases the risk of too much bleeding during certain procedures. This medication increases the production of platelets by your body to help prevent too much bleeding from the procedure.

How is this Vancocin Italia Srl product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84230055107. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84230-551-07
11-Digit CMS (5-4-2)
84230-0551-07

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.